BioRestorative Therapies, Inc. Reports Promising Phase 2 Clinical Trial Results for BRTX-100 at ISSCR 2025 Annual Meeting
13/6 13:50
BioRestorative presents promising Phase 2 trial data for BRTX-100, showing significant pain and function improvements in chronic lumbar disc disease....